Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results
Q3 2024 OvaSuiteSM revenue of $2.3 million and volume of 6,001 unitsCash utilization for the third quarter was $2.9 million, a decrease of 12% ...
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCQB: EVFM) today announced financial results for the third quarter and ...